StockData
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31

Innoviva, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$21.08+0.30 (+1.44%)

Close on Oct 19, 2026

Market cap
$1.55B
P/E (TTM)
5.2
Dividend yield
–

Innoviva statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureInnovivaIndustry median
Market Cap$1.52B$197.05M
Enterprise Value$1.21B$106.56M
PE Ratio5.1720.52
PS Ratio3.463.93
PB Ratio1.232.14
P/TBV Ratio1.462.46
P/FCF Ratio8.0418.25
P/OCF Ratio7.9513.78

Enterprise value

MeasureInnovivaIndustry median
EV / Sales2.752.69
EV / EBITDA7.4514.86
EV / EBIT7.4519.00
EV / FCF6.3921.02

Income (trailing twelve months)

MeasureInnovivaIndustry median
Revenue$440.00M$57.94M
Gross Profit$317.66M$90.47M
Operating Income$162.58M-$21.44M
Pretax Income$419.40M-$14.45M
EBITDA$162.58M-$16.91M
EPS (Diluted)$4.08-$0.83

Margins

MeasureInnovivaIndustry median
Gross Margin72.2%52.3%
Operating Margin36.9%-44.5%
Pretax Margin95.3%-13.0%
EBITDA Margin36.9%-31.3%
FCF Margin43.1%-8.85%

Returns

MeasureInnovivaIndustry median
Return on Invested Capital (ROIC)15.0%-32.0%
Return on Capital Employed (ROCE)9.82%-37.8%

Growth

MeasureInnovivaIndustry median
Revenue Growth (YoY)18.8%6.01%
FCF Growth (YoY)-5.44%2.34%
Revenue Growth (3Y CAGR)7.47%2.25%
Revenue Growth (5Y CAGR)4.08%6.42%
EPS Growth (3Y CAGR)11.7%-0.17%
EPS Growth (5Y CAGR)10.3%3.77%

Balance sheet

MeasureInnovivaIndustry median
Cash & Short-Term Investments$570.39M$62.42M
Total Debt$258.45M$120.13M
Net Cash (Debt)$311.93M$15.68M
Net Cash Per Share$4.32$0.65
Equity (Book Value)$1.23B$48.79M
Book Value Per Share$17.07$1.36
Tangible Book Value$1.05B$23.06M
Working Capital$706.30M$75.77M

Financial position

MeasureInnovivaIndustry median
Current Ratio16.013.30
Quick Ratio13.202.39
Debt / Equity0.210.51
Debt / EBITDA1.593.35
Debt / FCF1.365.05
Net Debt / EBITDA-1.922.22
Interest Coverage8.92-7.12

Cash flow (trailing twelve months)

MeasureInnovivaIndustry median
Operating Cash Flow$191.49M-$12.35M
Capital Expenditures-$2.05M-$1.06M
Free Cash Flow$189.44M-$20.28M
FCF Per Share$2.62-$0.41

Efficiency

MeasureInnovivaIndustry median
Asset Turnover0.290.38
Inventory Turnover2.782.67
Revenue Per Employee$2.77M$398.96K
Employee Count15973

Dividends and yields

MeasureInnovivaIndustry median
FCF Yield12.4%-7.64%
Buyback Yield3.47%-0.58%
Shareholder Yield3.47%0.00%

Shares

MeasureInnovivaIndustry median
Shares Outstanding72,245,50059,128,900
Shares Change (YoY)3.38%11.1%
Shares Change (QoQ)-1.59%0.54%
Float68,356,40048,744,500
Shares Held by Insiders5.38%11.8%
Shares Held by Institutions104.1%59.4%

Taxes

MeasureInnovivaIndustry median
Income Tax$62.16M$91.50K
Effective Tax Rate14.8%20.6%

Scores

MeasureInnovivaIndustry median
Graham Number$39.59$17.36
Graham Upside87.8%-45.5%
Altman Z-Score3.320.10

Calculated by StockData from Innoviva's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.